CPWR’s Construction Safety and Health podcast series has added a new podcast, “COVID 101: Back to Basics”. Dr. Doug Trout, Medical Officer at the NIOSH Office of Construction Safety and Health, reviews the importance of a multi-layered approach to exposure prevention when dealing with COVID-19 on construction sites.
All content shared by Network members can be found in this searchable database. We invite you to explore and share the content with your own network.
New Podcast – COVID 101: Back to Basics
CPWR’s New Safety Climate-Safety Management Information System (SC-SMIS)
CPWR Data Bulletin: Construction Worker Mental Health During the COVID-19 Pandemic
This issue of the CPWR Data Bulletin examines anxiety and depression symptoms or medication use among construction workers before and during the COVID-19 pandemic. Accompanying the Data Bulletin are two Data Dashboards related to construction workers’ health. One provides detailed information on mental health, including anxiety, depression, and psychological distress; the other explores medical expenditures, healthcare, and the impact of health insurance.
Latest Podcast Discusses the CPWR Data Center
CPWR’s Construction Safety and Health podcast series has added a new podcast on the Data Center, a leading source of detailed statistics and analyses of key trends in construction safety and health, and the publications, interactive dashboards, and other resources it produces.
New! COVID-19 Vaccine Infographics
CPWR continues to provide the construction industry current information about COVID-19 vaccinations with five new infographics based on our COVID-19 Vaccine FAQs resource. These infographics, which provide simple, straightforward information on COVID-19 vaccines, were created with support from the University of Michigan School of Public Health, the National Institute for Occupational Safety & Health (NIOSH), and the NORA Construction Sector Council COVID-19 Work Group. They cover topics such as population immunity, who should get the vaccine, its effectiveness, side effects, and breakthrough infections.